BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
JB Chemicals Inks INR 1,089 Cr Deal, Acquires around 15 Ophthalmology Drugs December 20, 2023 Over the next three years, during the duration of the in-licensing agreement, Novartis will continue the manufacturing of the drugs, while JB Chemicals will focus on marketing and selling the products.
Page 1 of 1
